Interestingly, it was shown via immunohistochemistry that the expression of estrogen receptors in FISSs, but not the expression of progesterone receptors, correlated with clinical and histopathological aspects (mitotic index and degree of pleomorphism) and thus, estrogen receptors expression could influence tumor growth [79]. The gene discussed is ESR1; the disease is neoplasm.